Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding
This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.
- This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.
- Comprehensive laboratory testing of the samples is conducted by the Center for Forensic Science Research and Education (CFSRE) .
- CSFRE testing methods facilitate detection of over one thousand analytes (prescription drugs and illicit substances, including novel emerging substances).
- Led by medical toxicology physicians and registry experts, our projects involve case registry design and maintenance.